Importantly, the treatment with Cas13d-S24 or Cas13d-S30 led to a significant reduction in poly-GP and poly-GA levels in the C9-500 BAC mice, consistent with the findings observed in C9orf72 repeat–associated ALS patient cells. Here, C9 is linked to amyotrophic lateral sclerosis.